BioCentury | Jun 14, 2004
Company News

Xcellsyz, Boehringer Ingelheim deal

...for its human skeletal muscle cell lines to Boehringer for evaluation and drug discovery research. Xcellsyz Ltd....
BioCentury | Apr 5, 2004
Company News

Geron, Xcellsyz deal

...GERN granted Xcellsyz a non-exclusive license to GERN's human telomerase reverse transcriptase (hTERT) technology for research...
...transcriptase (hTERT) technology for research applications and the development of research products. Under the deal, Xcellsyz...
...and equity in Xcellsyz, and is eligible for royalties. Geron Corp. (GERN), Menlo Park, Calif. Xcellsyz Ltd....
BioCentury | Mar 29, 2004
Company News

Geron, Xcellsyz hTERT deal

...GERN granted Xcellsyz (Newcastle, U.K.) a non-exclusive license to GERN's human telomerase reverse transcriptase (hTERT) technology...
...transcriptase (hTERT) technology for research applications and the development of research products. Under the deal, Xcellsyz...
...made using Xcellsyz's own technology. GERN will receive a cash license fee and equity in Xcellsyz...
BioCentury | May 5, 2003
Company News

Xcellsyz management update

Xcellsyz Ltd. , Newcastle-upon-Tyne, U.K. Business: Metabolic Hired: Ian Hallett as business development director, formerly business development manager at Quintiles Transnational Corp. WIR Staff...
BioCentury | Mar 17, 2003
Company News

Xcellsyz management update

Xcellsyz Ltd. , Newcastle-upon-Tyne, U.K. Business: Metabolic Hired: Brad Hoy as CEO, formerly senior director of Geron BioMed Ltd., the U.K. subsidiary of Geron Corp. ; he replaces acting CEO Peter Shepherd who will remain CSO...
BioCentury | Mar 12, 2003
Company News

Xcellsyz names Hoy as CEO

...Diabetes and obesity company Xcellsyz (Newcastle-Upon-Tyne, U.K.) hired Brad Hoy as CEO. He replaces acting CEO...
BioCentury | Jul 30, 2001
Company News

Xcellsyz names CEO

...European high throughput drug discovery play Xcellsyz hired Dimitri Dimitriou as CEO. Dimitriou was most recently...
BioCentury | Jul 30, 2001
Company News

Xcellsyz board of directors update

Xcellsyz Ltd. , London, U.K. Business: Gene/Cell therapy Hired: Dimitri Dimitirou as CEO, formerly senior director of worldwide business development at GlaxoSmithKline plc WIR Staff...
BioCentury | Mar 5, 2001
Finance

Ebb & Flow

...000 ($362.500) in qualifying U.K. companies. The fund recently invested in cell-based drug discovery company Xcellsyz...
Items per page:
1 - 9 of 9
BioCentury | Jun 14, 2004
Company News

Xcellsyz, Boehringer Ingelheim deal

...for its human skeletal muscle cell lines to Boehringer for evaluation and drug discovery research. Xcellsyz Ltd....
BioCentury | Apr 5, 2004
Company News

Geron, Xcellsyz deal

...GERN granted Xcellsyz a non-exclusive license to GERN's human telomerase reverse transcriptase (hTERT) technology for research...
...transcriptase (hTERT) technology for research applications and the development of research products. Under the deal, Xcellsyz...
...and equity in Xcellsyz, and is eligible for royalties. Geron Corp. (GERN), Menlo Park, Calif. Xcellsyz Ltd....
BioCentury | Mar 29, 2004
Company News

Geron, Xcellsyz hTERT deal

...GERN granted Xcellsyz (Newcastle, U.K.) a non-exclusive license to GERN's human telomerase reverse transcriptase (hTERT) technology...
...transcriptase (hTERT) technology for research applications and the development of research products. Under the deal, Xcellsyz...
...made using Xcellsyz's own technology. GERN will receive a cash license fee and equity in Xcellsyz...
BioCentury | May 5, 2003
Company News

Xcellsyz management update

Xcellsyz Ltd. , Newcastle-upon-Tyne, U.K. Business: Metabolic Hired: Ian Hallett as business development director, formerly business development manager at Quintiles Transnational Corp. WIR Staff...
BioCentury | Mar 17, 2003
Company News

Xcellsyz management update

Xcellsyz Ltd. , Newcastle-upon-Tyne, U.K. Business: Metabolic Hired: Brad Hoy as CEO, formerly senior director of Geron BioMed Ltd., the U.K. subsidiary of Geron Corp. ; he replaces acting CEO Peter Shepherd who will remain CSO...
BioCentury | Mar 12, 2003
Company News

Xcellsyz names Hoy as CEO

...Diabetes and obesity company Xcellsyz (Newcastle-Upon-Tyne, U.K.) hired Brad Hoy as CEO. He replaces acting CEO...
BioCentury | Jul 30, 2001
Company News

Xcellsyz names CEO

...European high throughput drug discovery play Xcellsyz hired Dimitri Dimitriou as CEO. Dimitriou was most recently...
BioCentury | Jul 30, 2001
Company News

Xcellsyz board of directors update

Xcellsyz Ltd. , London, U.K. Business: Gene/Cell therapy Hired: Dimitri Dimitirou as CEO, formerly senior director of worldwide business development at GlaxoSmithKline plc WIR Staff...
BioCentury | Mar 5, 2001
Finance

Ebb & Flow

...000 ($362.500) in qualifying U.K. companies. The fund recently invested in cell-based drug discovery company Xcellsyz...
Items per page:
1 - 9 of 9